The national drug pricing debate is in full swing -- with the White House, Congress, industry, states and consumer groups all weighing in. Now is the time to take advantage of the detailed, forward-looking reporting from Inside Health Policy and our latest service, Inside Drug Pricing. Exclusive stories, blogs, documents and a weekly newsletter -- all on drug pricing. .

Sign up for 30 days of no-obligation access for all the essential news during this critical time -- you'll be able to choose one of our online services as part of your trial: Inside CMS, FDA Week, Health Exchange Alert or Inside Drug Pricing.


Top Story

Trump Administration Proposes To Deny Green Cards For Those With Medicaid, Part D Low-Income Subsidies; But Not ACA Subsidies

The Trump administration has proposed a rule that would allow the government to deny green cards for immigrants who receive Medicare Part D low-income subsidies or Medicaid, but, in a departure from leaked drafts, the proposal wouldn’t target immigrants who receive Affordable Care Act subsidies.

Latest News

Seniors advocacy groups joined dozens of other patient groups, unions and insurers in a letter urging CMS to once again extend Part B penalty relief for Medicare-eligible individuals who are, or were recently enrolled in, exchange coverage and could otherwise be charged a late fee for failing to enroll on time.

CMS is gathering feedback on Alabama's Medicaid work-requirement proposal, which is one of the most stringent that the agency has received and comes from a state with the lowest Medicaid eligibility ceiling in the country.

FDA issued two guidances on Monday (Sept. 24) -- one final and one draft -- aimed at streamlining the review process for generic, brand and biologics drugs and helping developers submit high-quality applications from the get-go to avoid going through multiple review cycles, the agency announced Monday (Sept. 24).

Six GOP-led states doubled down Friday (Sept. 21) on an effort to block the IRS from collecting an Obamacare tax that Medicaid plans are required to pay Oct. 1.

Former CMS officials, a Democrat and a Republican, discussed the intense political pressure CMS staff would be subject to if Medicare were to negotiate drug prices, and they said the current system is preferable.

The Advanced Medical Technology Association (AdvaMed) President and CEO Scott Whitaker is upset the Senate tucked into its recently passed opioid bill a provision expanding the sunshine law to require that drug and medical device makers also publicly disclose payments made to nurse practitioners, physician assistants and midwives – not just doctors and hospitals – for promotional talks, consulting and other interactions.

Rep. Suzan DelBene (D-WA) is drumming up support for a letter that will ask CMS to adjust the low-volume threshold in order to include more providers in the Merit-based Incentive Payment System as part of the final 2019 physician fee schedule – an agency move that would be supported by some stakeholders like Premier and the American Medical Group Association even though the American Medical Association and others want CMS to finalize the exemption as proposed.

Sen. Chuck Grassley (R-IA) is pressing FDA to provide more information about its recent spate of warning letters and civil monetary penalties to more than 1,300 e-cigarette companies.